HEADER OXIDOREDUCTASE 10-FEB-16 5FVP TITLE STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE HEME DOMAIN IN COMPLEX TITLE 2 WITH 4-METHYL-6-[2-(5-MORPHOLIN-4-YLPYRIDIN-3-YL)ETHYL]PYRIDIN-2- TITLE 3 AMINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: NITRIC OXIDE SYNTHASE, BRAIN; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: HEME DOMAIN, RESIDUES 297-718; COMPND 5 SYNONYM: BNOS, CONSTITUTIVE NOS, NC-NOS, NOS TYPE I, NEURONAL NOS, N COMPND 6 -NOS, NNOS, PEPTIDYL-CYSTEINE S-NITROSYLASE NOS1, NEURONAL NITRIC COMPND 7 OXIDE SYNTHASE; COMPND 8 EC: 1.14.13.39; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: RATTUS NORVEGICUS; SOURCE 3 ORGANISM_COMMON: NORWAY RAT; SOURCE 4 ORGANISM_TAXID: 10116; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PCWORI KEYWDS OXIDOREDUCTASE, NITRIC OXIDE SYNTHASE, INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR H.LI,T.L.POULOS REVDAT 3 08-MAY-24 5FVP 1 REMARK LINK REVDAT 2 08-JUN-16 5FVP 1 JRNL REVDAT 1 20-APR-16 5FVP 0 JRNL AUTH H.WANG,Y.QIN,H.LI,L.J.ROMAN,P.MARTASEK,T.L.POULOS, JRNL AUTH 2 R.B.SILVERMAN JRNL TITL POTENT AND SELECTIVE HUMAN NEURONAL NITRIC OXIDE SYNTHASE JRNL TITL 2 INHIBITION BY OPTIMIZATION OF THE 2-AMINOPYRIDINE-BASED JRNL TITL 3 SCAFFOLD WITH A PYRIDINE LINKER. JRNL REF J.MED.CHEM. V. 59 4913 2016 JRNL REFN ISSN 0022-2623 JRNL PMID 27050842 JRNL DOI 10.1021/ACS.JMEDCHEM.6B00273 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.99 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 71.3 REMARK 3 NUMBER OF REFLECTIONS : 40036 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.176 REMARK 3 R VALUE (WORKING SET) : 0.173 REMARK 3 FREE R VALUE : 0.232 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 1979 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 40.9978 - 5.0556 0.96 3913 201 0.1466 0.1819 REMARK 3 2 5.0556 - 4.0139 0.98 3762 220 0.1220 0.1802 REMARK 3 3 4.0139 - 3.5068 0.98 3771 197 0.1428 0.2285 REMARK 3 4 3.5068 - 3.1863 0.99 3807 177 0.1708 0.2121 REMARK 3 5 3.1863 - 2.9580 0.99 3744 219 0.1991 0.2552 REMARK 3 6 2.9580 - 2.7836 0.99 3756 205 0.2025 0.2873 REMARK 3 7 2.7836 - 2.6443 0.99 3785 180 0.2308 0.3104 REMARK 3 8 2.6443 - 2.5292 0.99 3723 190 0.2356 0.2890 REMARK 3 9 2.5292 - 2.4318 0.66 2510 127 0.2476 0.3691 REMARK 3 10 2.4318 - 2.3479 0.47 1758 82 0.2470 0.2771 REMARK 3 11 2.3479 - 2.2745 0.35 1296 73 0.2259 0.2304 REMARK 3 12 2.2745 - 2.2095 0.26 985 64 0.2618 0.3108 REMARK 3 13 2.2095 - 2.1513 0.19 720 26 0.2167 0.3195 REMARK 3 14 2.1513 - 2.0988 0.14 527 18 0.2114 0.4512 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.260 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 27.000 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 28.96 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 64.25 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 7067 REMARK 3 ANGLE : 1.229 9615 REMARK 3 CHIRALITY : 0.074 993 REMARK 3 PLANARITY : 0.005 1216 REMARK 3 DIHEDRAL : 15.484 2577 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: (CHAIN A AND RESID 299:716) REMARK 3 ORIGIN FOR THE GROUP (A): 11.2810 4.7624 22.4140 REMARK 3 T TENSOR REMARK 3 T11: 0.1001 T22: 0.1755 REMARK 3 T33: 0.2003 T12: -0.0105 REMARK 3 T13: 0.0035 T23: -0.0168 REMARK 3 L TENSOR REMARK 3 L11: 0.9590 L22: 1.7750 REMARK 3 L33: 8.3449 L12: -0.1744 REMARK 3 L13: -0.4533 L23: -0.6352 REMARK 3 S TENSOR REMARK 3 S11: -0.0820 S12: 0.1538 S13: -0.0161 REMARK 3 S21: 0.1105 S22: -0.0972 S23: 0.0721 REMARK 3 S31: 0.0767 S32: -0.5218 S33: 0.0812 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: (CHAIN B AND RESID 299:718) REMARK 3 ORIGIN FOR THE GROUP (A): 12.1607 4.7835 59.6514 REMARK 3 T TENSOR REMARK 3 T11: 0.1013 T22: 0.1634 REMARK 3 T33: 0.1832 T12: 0.0279 REMARK 3 T13: 0.0437 T23: 0.0273 REMARK 3 L TENSOR REMARK 3 L11: 1.0188 L22: 1.6693 REMARK 3 L33: 4.0441 L12: -0.1991 REMARK 3 L13: -0.0510 L23: 0.6035 REMARK 3 S TENSOR REMARK 3 S11: -0.0046 S12: 0.0200 S13: 0.0945 REMARK 3 S21: -0.1694 S22: -0.0745 S23: -0.0326 REMARK 3 S31: 0.0376 S32: 0.1199 S33: 0.0321 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: RESIDUES 339-349 IN CHAIN A AND 339-347 REMARK 3 IN CHAIN B ARE DISORDERED. REMARK 4 REMARK 4 5FVP COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 10-FEB-16. REMARK 100 THE DEPOSITION ID IS D_1290065892. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-AUG-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 8.2.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 55617 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 200 DATA REDUNDANCY : 3.900 REMARK 200 R MERGE (I) : 0.09000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.14 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.3 REMARK 200 DATA REDUNDANCY IN SHELL : 3.50 REMARK 200 R MERGE FOR SHELL (I) : 1.00000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 0.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: OTHER REMARK 200 SOFTWARE USED: REFMAC REMARK 200 STARTING MODEL: NONE REMARK 200 REMARK 200 REMARK: OVERALL RMERGE 0.091 RPIM 0.059 HIGHEST RESOLUTION SHELL REMARK 200 RMERGE HIGHER THAN 1.00 RPIM 0.997 CC ONE HALF 0.335 REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.40 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.48 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20-24% PEG3350, 0.1M MES 0.14-0.20M REMARK 280 AMMONIUM ACETATE, 10% ETHYLENE GLYCOL, 30UM SDS 5 MM GSH, PH 5.8 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 25.77000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 81.98000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 55.68000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 81.98000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 25.77000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 55.68000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 9620 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 33020 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -84.5 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 CYS A 297 REMARK 465 PRO A 298 REMARK 465 SER A 339 REMARK 465 GLN A 340 REMARK 465 HIS A 341 REMARK 465 THR A 342 REMARK 465 ARG A 343 REMARK 465 LYS A 344 REMARK 465 PRO A 345 REMARK 465 GLU A 346 REMARK 465 ASP A 347 REMARK 465 VAL A 348 REMARK 465 ARG A 349 REMARK 465 GLY A 718 REMARK 465 CYS B 297 REMARK 465 PRO B 298 REMARK 465 SER B 339 REMARK 465 GLN B 340 REMARK 465 HIS B 341 REMARK 465 THR B 342 REMARK 465 ARG B 343 REMARK 465 LYS B 344 REMARK 465 PRO B 345 REMARK 465 GLU B 346 REMARK 465 ASP B 347 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 717 CA C O CB CG CD CE REMARK 470 LYS A 717 NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OH TYR B 706 O2D HEM B 750 2.00 REMARK 500 OH TYR A 706 O2D HEM A 750 2.09 REMARK 500 OG SER A 684 OD2 ASP B 627 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 309 -0.68 59.57 REMARK 500 THR A 466 -91.51 -114.88 REMARK 500 ARG A 514 41.42 33.14 REMARK 500 LYS A 550 -41.32 -132.97 REMARK 500 CYS A 582 61.47 -155.08 REMARK 500 ARG A 603 -128.13 -128.35 REMARK 500 SER A 684 19.97 57.55 REMARK 500 SER B 392 -0.06 67.33 REMARK 500 THR B 466 -88.33 -117.16 REMARK 500 CYS B 582 63.00 -153.06 REMARK 500 ARG B 603 -138.75 -126.77 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN B 900 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 326 SG REMARK 620 2 CYS A 331 SG 113.3 REMARK 620 3 CYS B 326 SG 120.0 103.8 REMARK 620 4 CYS B 331 SG 104.1 100.9 113.4 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM A 750 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 415 SG REMARK 620 2 HEM A 750 NA 102.1 REMARK 620 3 HEM A 750 NB 102.3 86.8 REMARK 620 4 HEM A 750 NC 101.4 156.4 86.0 REMARK 620 5 HEM A 750 ND 103.8 85.9 153.8 90.8 REMARK 620 N 1 2 3 4 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM B 750 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS B 415 SG REMARK 620 2 HEM B 750 NA 100.9 REMARK 620 3 HEM B 750 NB 99.3 85.6 REMARK 620 4 HEM B 750 NC 94.8 164.2 89.9 REMARK 620 5 HEM B 750 ND 98.9 92.8 161.7 86.7 REMARK 620 N 1 2 3 4 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM A 750 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE H4B A 760 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE WOS A 800 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 860 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM B 750 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE H4B B 760 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE WOS B 800 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT B 860 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN B 900 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5FVO RELATED DB: PDB REMARK 900 STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE HEME DOMAIN IN REMARK 900 COMPLEX WITH 6-(2-(5-(3-METHOXYPROPYLAMINO) PYRIDIN-3-YL)ETHYL)-4- REMARK 900 METHYLPYRIDIN-2-AMINE REMARK 900 RELATED ID: 5FVQ RELATED DB: PDB REMARK 900 STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE HEME DOMAIN IN REMARK 900 COMPLEX WITH 4-METHYL-6-(2-(5-(4- METHYLPIPERAZIN-1-YL)PYRIDIN-3-YL) REMARK 900 ETHYL)PYRIDIN-2- AMINE REMARK 900 RELATED ID: 5FVR RELATED DB: PDB REMARK 900 STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE HEME DOMAIN IN REMARK 900 COMPLEX WITH 4-METHYL-6-(2-(5-(1- METHYLPIPERIDIN-4-YL)PYRIDIN-3-YL) REMARK 900 ETHYL)PYRIDIN-2- AMINE REMARK 900 RELATED ID: 5FVS RELATED DB: PDB REMARK 900 STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE HEME DOMAIN IN REMARK 900 COMPLEX WITH 4-METHYL-6-(2-(5-(3-( METHYLAMINO)PROPYL)PYRIDIN-3-YL) REMARK 900 ETHYL)PYRIDIN-2-AMINE REMARK 900 RELATED ID: 5FVT RELATED DB: PDB REMARK 900 STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE HEME DOMAIN IN REMARK 900 COMPLEX WITH 6-(2-(5-(3-(DIMETHYLAMINO) PROPYL)PYRIDIN-3-YL)ETHYL)- REMARK 900 4-METHYLPYRIDIN-2-AMINE REMARK 900 RELATED ID: 5FVU RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN NNOS R354A G357D MUTANT HEME DOMAIN IN COMPLEX REMARK 900 WITH 4-METHYL-6-(2-(5-(4- METHYLPIPERAZIN-1-YL)PYRIDIN-3-YL)ETHYL) REMARK 900 PYRIDIN-2- AMINE REMARK 900 RELATED ID: 5FVV RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN NNOS R354A G357D MUTANT HEME DOMAIN IN COMPLEX REMARK 900 WITH 4-METHYL-6-(2-(5-(1- METHYLPIPERIDIN-4-YL)PYRIDIN-3-YL)ETHYL) REMARK 900 PYRIDIN-2- AMINE REMARK 900 RELATED ID: 5FVW RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN NNOS R354A G357D MUTANT HEME DOMAIN IN COMPLEX REMARK 900 WITH 4-METHYL-6-(2-(5-(3-(METHYLAMINO) PROPYL)PYRIDIN-3-YL)ETHYL) REMARK 900 PYRIDIN-2-AMINE REMARK 900 RELATED ID: 5FVX RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN NNOS R354A G357D MUTANT HEME DOMAIN IN COMPLEX REMARK 900 WITH HW67 REMARK 900 RELATED ID: 5FVY RELATED DB: PDB REMARK 900 STRUCTURE OF BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN REMARK 900 IN COMPLEX WITH 4-METHYL-6-(2-(5-(4- METHYLPIPERAZIN-1-YL)PYRIDIN-3- REMARK 900 YL)ETHYL)PYRIDIN-2- AMINE REMARK 900 RELATED ID: 5FVZ RELATED DB: PDB REMARK 900 STRUCTURE OF BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN REMARK 900 IN COMPLEX WITH 6-(2-(5-(3-( DIMETHYLAMINO)PROPYL)PYRIDIN-3-YL) REMARK 900 ETHYL)-4-METHYLPYRIDIN -2-AMINE REMARK 900 RELATED ID: 5FW0 RELATED DB: PDB REMARK 900 STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE HEME DOMAIN IN REMARK 900 COMPLEX WITH 6-(2-(5-((2-METHOXYETHYL)( METHYL)AMINO)PYRIDIN-3-YL) REMARK 900 ETHYL)-4-METHYLPYRIDIN-2- AMINE DBREF 5FVP A 297 718 UNP P29476 NOS1_RAT 297 718 DBREF 5FVP B 297 718 UNP P29476 NOS1_RAT 297 718 SEQRES 1 A 422 CYS PRO ARG PHE LEU LYS VAL LYS ASN TRP GLU THR ASP SEQRES 2 A 422 VAL VAL LEU THR ASP THR LEU HIS LEU LYS SER THR LEU SEQRES 3 A 422 GLU THR GLY CYS THR GLU HIS ILE CYS MET GLY SER ILE SEQRES 4 A 422 MET LEU PRO SER GLN HIS THR ARG LYS PRO GLU ASP VAL SEQRES 5 A 422 ARG THR LYS ASP GLN LEU PHE PRO LEU ALA LYS GLU PHE SEQRES 6 A 422 LEU ASP GLN TYR TYR SER SER ILE LYS ARG PHE GLY SER SEQRES 7 A 422 LYS ALA HIS MET ASP ARG LEU GLU GLU VAL ASN LYS GLU SEQRES 8 A 422 ILE GLU SER THR SER THR TYR GLN LEU LYS ASP THR GLU SEQRES 9 A 422 LEU ILE TYR GLY ALA LYS HIS ALA TRP ARG ASN ALA SER SEQRES 10 A 422 ARG CYS VAL GLY ARG ILE GLN TRP SER LYS LEU GLN VAL SEQRES 11 A 422 PHE ASP ALA ARG ASP CYS THR THR ALA HIS GLY MET PHE SEQRES 12 A 422 ASN TYR ILE CYS ASN HIS VAL LYS TYR ALA THR ASN LYS SEQRES 13 A 422 GLY ASN LEU ARG SER ALA ILE THR ILE PHE PRO GLN ARG SEQRES 14 A 422 THR ASP GLY LYS HIS ASP PHE ARG VAL TRP ASN SER GLN SEQRES 15 A 422 LEU ILE ARG TYR ALA GLY TYR LYS GLN PRO ASP GLY SER SEQRES 16 A 422 THR LEU GLY ASP PRO ALA ASN VAL GLN PHE THR GLU ILE SEQRES 17 A 422 CYS ILE GLN GLN GLY TRP LYS ALA PRO ARG GLY ARG PHE SEQRES 18 A 422 ASP VAL LEU PRO LEU LEU LEU GLN ALA ASN GLY ASN ASP SEQRES 19 A 422 PRO GLU LEU PHE GLN ILE PRO PRO GLU LEU VAL LEU GLU SEQRES 20 A 422 VAL PRO ILE ARG HIS PRO LYS PHE ASP TRP PHE LYS ASP SEQRES 21 A 422 LEU GLY LEU LYS TRP TYR GLY LEU PRO ALA VAL SER ASN SEQRES 22 A 422 MET LEU LEU GLU ILE GLY GLY LEU GLU PHE SER ALA CYS SEQRES 23 A 422 PRO PHE SER GLY TRP TYR MET GLY THR GLU ILE GLY VAL SEQRES 24 A 422 ARG ASP TYR CYS ASP ASN SER ARG TYR ASN ILE LEU GLU SEQRES 25 A 422 GLU VAL ALA LYS LYS MET ASP LEU ASP MET ARG LYS THR SEQRES 26 A 422 SER SER LEU TRP LYS ASP GLN ALA LEU VAL GLU ILE ASN SEQRES 27 A 422 ILE ALA VAL LEU TYR SER PHE GLN SER ASP LYS VAL THR SEQRES 28 A 422 ILE VAL ASP HIS HIS SER ALA THR GLU SER PHE ILE LYS SEQRES 29 A 422 HIS MET GLU ASN GLU TYR ARG CYS ARG GLY GLY CYS PRO SEQRES 30 A 422 ALA ASP TRP VAL TRP ILE VAL PRO PRO MET SER GLY SER SEQRES 31 A 422 ILE THR PRO VAL PHE HIS GLN GLU MET LEU ASN TYR ARG SEQRES 32 A 422 LEU THR PRO SER PHE GLU TYR GLN PRO ASP PRO TRP ASN SEQRES 33 A 422 THR HIS VAL TRP LYS GLY SEQRES 1 B 422 CYS PRO ARG PHE LEU LYS VAL LYS ASN TRP GLU THR ASP SEQRES 2 B 422 VAL VAL LEU THR ASP THR LEU HIS LEU LYS SER THR LEU SEQRES 3 B 422 GLU THR GLY CYS THR GLU HIS ILE CYS MET GLY SER ILE SEQRES 4 B 422 MET LEU PRO SER GLN HIS THR ARG LYS PRO GLU ASP VAL SEQRES 5 B 422 ARG THR LYS ASP GLN LEU PHE PRO LEU ALA LYS GLU PHE SEQRES 6 B 422 LEU ASP GLN TYR TYR SER SER ILE LYS ARG PHE GLY SER SEQRES 7 B 422 LYS ALA HIS MET ASP ARG LEU GLU GLU VAL ASN LYS GLU SEQRES 8 B 422 ILE GLU SER THR SER THR TYR GLN LEU LYS ASP THR GLU SEQRES 9 B 422 LEU ILE TYR GLY ALA LYS HIS ALA TRP ARG ASN ALA SER SEQRES 10 B 422 ARG CYS VAL GLY ARG ILE GLN TRP SER LYS LEU GLN VAL SEQRES 11 B 422 PHE ASP ALA ARG ASP CYS THR THR ALA HIS GLY MET PHE SEQRES 12 B 422 ASN TYR ILE CYS ASN HIS VAL LYS TYR ALA THR ASN LYS SEQRES 13 B 422 GLY ASN LEU ARG SER ALA ILE THR ILE PHE PRO GLN ARG SEQRES 14 B 422 THR ASP GLY LYS HIS ASP PHE ARG VAL TRP ASN SER GLN SEQRES 15 B 422 LEU ILE ARG TYR ALA GLY TYR LYS GLN PRO ASP GLY SER SEQRES 16 B 422 THR LEU GLY ASP PRO ALA ASN VAL GLN PHE THR GLU ILE SEQRES 17 B 422 CYS ILE GLN GLN GLY TRP LYS ALA PRO ARG GLY ARG PHE SEQRES 18 B 422 ASP VAL LEU PRO LEU LEU LEU GLN ALA ASN GLY ASN ASP SEQRES 19 B 422 PRO GLU LEU PHE GLN ILE PRO PRO GLU LEU VAL LEU GLU SEQRES 20 B 422 VAL PRO ILE ARG HIS PRO LYS PHE ASP TRP PHE LYS ASP SEQRES 21 B 422 LEU GLY LEU LYS TRP TYR GLY LEU PRO ALA VAL SER ASN SEQRES 22 B 422 MET LEU LEU GLU ILE GLY GLY LEU GLU PHE SER ALA CYS SEQRES 23 B 422 PRO PHE SER GLY TRP TYR MET GLY THR GLU ILE GLY VAL SEQRES 24 B 422 ARG ASP TYR CYS ASP ASN SER ARG TYR ASN ILE LEU GLU SEQRES 25 B 422 GLU VAL ALA LYS LYS MET ASP LEU ASP MET ARG LYS THR SEQRES 26 B 422 SER SER LEU TRP LYS ASP GLN ALA LEU VAL GLU ILE ASN SEQRES 27 B 422 ILE ALA VAL LEU TYR SER PHE GLN SER ASP LYS VAL THR SEQRES 28 B 422 ILE VAL ASP HIS HIS SER ALA THR GLU SER PHE ILE LYS SEQRES 29 B 422 HIS MET GLU ASN GLU TYR ARG CYS ARG GLY GLY CYS PRO SEQRES 30 B 422 ALA ASP TRP VAL TRP ILE VAL PRO PRO MET SER GLY SER SEQRES 31 B 422 ILE THR PRO VAL PHE HIS GLN GLU MET LEU ASN TYR ARG SEQRES 32 B 422 LEU THR PRO SER PHE GLU TYR GLN PRO ASP PRO TRP ASN SEQRES 33 B 422 THR HIS VAL TRP LYS GLY HET HEM A 750 43 HET H4B A 760 17 HET WOS A 800 22 HET ACT A 860 4 HET HEM B 750 43 HET H4B B 760 17 HET WOS B 800 22 HET ACT B 860 4 HET ZN B 900 1 HETNAM HEM PROTOPORPHYRIN IX CONTAINING FE HETNAM H4B 5,6,7,8-TETRAHYDROBIOPTERIN HETNAM WOS 4-METHYL-6-[2-(5-MORPHOLIN-4-YLPYRIDIN-3-YL) HETNAM 2 WOS ETHYL]PYRIDIN-2-AMINE HETNAM ACT ACETATE ION HETNAM ZN ZINC ION HETSYN HEM HEME FORMUL 3 HEM 2(C34 H32 FE N4 O4) FORMUL 4 H4B 2(C9 H15 N5 O3) FORMUL 5 WOS 2(C17 H22 N4 O) FORMUL 6 ACT 2(C2 H3 O2 1-) FORMUL 11 ZN ZN 2+ FORMUL 12 HOH *199(H2 O) HELIX 1 1 THR A 315 SER A 320 5 6 HELIX 2 2 THR A 350 ILE A 369 1 20 HELIX 3 3 SER A 374 SER A 392 1 19 HELIX 4 4 LYS A 397 ASN A 411 1 15 HELIX 5 5 GLY A 417 TRP A 421 5 5 HELIX 6 6 THR A 434 ASN A 451 1 18 HELIX 7 7 LYS A 452 ASN A 454 5 3 HELIX 8 8 ASN A 498 GLN A 508 1 11 HELIX 9 9 PRO A 537 VAL A 541 5 5 HELIX 10 10 PHE A 551 GLY A 558 5 8 HELIX 11 11 MET A 589 VAL A 595 1 7 HELIX 12 12 VAL A 595 ASP A 600 1 6 HELIX 13 13 ILE A 606 ASP A 615 1 10 HELIX 14 14 LYS A 620 SER A 623 5 4 HELIX 15 15 LEU A 624 ASP A 644 1 21 HELIX 16 16 ASP A 650 ARG A 669 1 20 HELIX 17 17 ASP A 675 VAL A 680 1 6 HELIX 18 18 SER A 684 THR A 688 5 5 HELIX 19 19 THR A 688 HIS A 692 5 5 HELIX 20 20 ASP A 709 HIS A 714 1 6 HELIX 21 21 THR B 315 SER B 320 5 6 HELIX 22 22 THR B 350 ILE B 369 1 20 HELIX 23 23 SER B 374 SER B 392 1 19 HELIX 24 24 LYS B 397 ASN B 411 1 15 HELIX 25 25 GLY B 417 TRP B 421 5 5 HELIX 26 26 THR B 434 ASN B 451 1 18 HELIX 27 27 LYS B 452 ASN B 454 5 3 HELIX 28 28 ASN B 498 GLN B 508 1 11 HELIX 29 29 PRO B 537 VAL B 541 5 5 HELIX 30 30 PHE B 551 GLY B 558 5 8 HELIX 31 31 GLY B 590 VAL B 595 1 6 HELIX 32 32 ILE B 606 MET B 614 1 9 HELIX 33 33 LYS B 620 SER B 623 5 4 HELIX 34 34 LEU B 624 ASP B 644 1 21 HELIX 35 35 ASP B 650 GLY B 670 1 21 HELIX 36 36 ASP B 675 VAL B 680 1 6 HELIX 37 37 SER B 684 THR B 688 5 5 HELIX 38 38 THR B 688 HIS B 692 5 5 HELIX 39 39 ASP B 709 THR B 713 5 5 SHEET 1 AA 2 LEU A 301 LYS A 304 0 SHEET 2 AA 2 VAL A 311 ASP A 314 -1 O LEU A 312 N VAL A 303 SHEET 1 AB 4 GLN A 425 ASP A 428 0 SHEET 2 AB 4 ALA A 458 ILE A 461 1 O ILE A 459 N PHE A 427 SHEET 3 AB 4 PHE A 584 SER A 585 -1 O SER A 585 N ALA A 458 SHEET 4 AB 4 ALA A 566 VAL A 567 -1 O VAL A 567 N PHE A 584 SHEET 1 AC 3 ARG A 473 VAL A 474 0 SHEET 2 AC 3 LEU A 522 GLN A 525 -1 O GLN A 525 N ARG A 473 SHEET 3 AC 3 GLU A 532 PHE A 534 -1 O GLU A 532 N LEU A 524 SHEET 1 AD 2 GLY A 484 LYS A 486 0 SHEET 2 AD 2 THR A 492 GLY A 494 -1 O LEU A 493 N TYR A 485 SHEET 1 AE 2 GLU A 543 PRO A 545 0 SHEET 2 AE 2 LYS A 560 TYR A 562 -1 O TRP A 561 N VAL A 544 SHEET 1 AF 3 LEU A 577 PHE A 579 0 SHEET 2 AF 3 LEU A 571 ILE A 574 -1 O LEU A 572 N PHE A 579 SHEET 3 AF 3 SER A 703 GLU A 705 -1 O SER A 703 N GLU A 573 SHEET 1 BA 2 LEU B 301 LYS B 304 0 SHEET 2 BA 2 VAL B 311 ASP B 314 -1 O LEU B 312 N VAL B 303 SHEET 1 BB 4 GLN B 425 ASP B 428 0 SHEET 2 BB 4 ALA B 458 ILE B 461 1 O ILE B 459 N PHE B 427 SHEET 3 BB 4 PHE B 584 SER B 585 -1 O SER B 585 N ALA B 458 SHEET 4 BB 4 ALA B 566 VAL B 567 -1 O VAL B 567 N PHE B 584 SHEET 1 BC 3 ARG B 473 VAL B 474 0 SHEET 2 BC 3 LEU B 522 GLN B 525 -1 O GLN B 525 N ARG B 473 SHEET 3 BC 3 GLU B 532 PHE B 534 -1 O GLU B 532 N LEU B 524 SHEET 1 BD 2 GLY B 484 LYS B 486 0 SHEET 2 BD 2 THR B 492 GLY B 494 -1 O LEU B 493 N TYR B 485 SHEET 1 BE 2 GLU B 543 PRO B 545 0 SHEET 2 BE 2 LYS B 560 TYR B 562 -1 O TRP B 561 N VAL B 544 SHEET 1 BF 3 LEU B 577 PHE B 579 0 SHEET 2 BF 3 LEU B 571 ILE B 574 -1 O LEU B 572 N PHE B 579 SHEET 3 BF 3 SER B 703 GLU B 705 -1 O SER B 703 N GLU B 573 SHEET 1 BG 2 TYR B 588 MET B 589 0 SHEET 2 BG 2 ILE B 648 VAL B 649 1 N VAL B 649 O TYR B 588 LINK SG CYS A 326 ZN ZN B 900 1555 1555 2.36 LINK SG CYS A 331 ZN ZN B 900 1555 1555 2.38 LINK SG CYS A 415 FE HEM A 750 1555 1555 2.31 LINK SG CYS B 326 ZN ZN B 900 1555 1555 2.33 LINK SG CYS B 331 ZN ZN B 900 1555 1555 2.45 LINK SG CYS B 415 FE HEM B 750 1555 1555 2.38 CISPEP 1 THR A 701 PRO A 702 0 -1.01 CISPEP 2 THR B 701 PRO B 702 0 -0.77 SITE 1 AC1 12 TRP A 409 CYS A 415 VAL A 416 SER A 457 SITE 2 AC1 12 PHE A 584 SER A 585 TRP A 587 TRP A 678 SITE 3 AC1 12 TYR A 706 H4B A 760 WOS A 800 HOH A2024 SITE 1 AC2 12 SER A 334 ARG A 596 VAL A 677 TRP A 678 SITE 2 AC2 12 HEM A 750 HOH A2082 HOH A2091 TRP B 676 SITE 3 AC2 12 PHE B 691 HIS B 692 GLN B 693 GLU B 694 SITE 1 AC3 7 VAL A 567 ASN A 569 GLY A 586 TRP A 587 SITE 2 AC3 7 TYR A 588 GLU A 592 HEM A 750 SITE 1 AC4 2 GLN A 420 TRP A 587 SITE 1 AC5 14 TRP B 409 ARG B 414 CYS B 415 SER B 457 SITE 2 AC5 14 PHE B 584 SER B 585 GLY B 586 TRP B 587 SITE 3 AC5 14 GLU B 592 TRP B 678 PHE B 704 TYR B 706 SITE 4 AC5 14 H4B B 760 WOS B 800 SITE 1 AC6 12 TRP A 676 PHE A 691 HIS A 692 GLN A 693 SITE 2 AC6 12 GLU A 694 SER B 334 ARG B 596 VAL B 677 SITE 3 AC6 12 TRP B 678 HEM B 750 HOH B2093 HOH B2103 SITE 1 AC7 7 VAL B 567 ASN B 569 PHE B 584 TRP B 587 SITE 2 AC7 7 GLU B 592 HEM B 750 HOH B2058 SITE 1 AC8 3 ILE B 419 TRP B 587 VAL B 649 SITE 1 AC9 4 CYS A 326 CYS A 331 CYS B 326 CYS B 331 CRYST1 51.540 111.360 163.960 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019402 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008980 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006099 0.00000